Physician profile
Ugonna Ezeh
NPI 1629423223
$4,132.24
in general payments reported to CMS, 2019-2025
9 companies · $391 in 2025
The $391 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $31.20 · 2021: $1,133 · 2022: $1,600 · 2023: $295 · 2024: $516 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,767.27 | 2021-2025 | Mako, Gamma |
| Zimmer Biomet Holdings, INC. | $691.79 | 2019-2024 | Persona |
| Depuy Synthes Sales INC. | $227.78 | 2021-2022 | |
| Davol INC. | $143.29 | 2022 | |
| Smith+Nephew, INC. | $99.41 | 2020-2024 | Pico |
| Vertex Pharmaceuticals Incorporated | $76.17 | 2025 | |
| Baxter Healthcare | $73.63 | 2023-2025 | Perclot, Tisseel |
| Sanofi-Aventis U.S. LLC | $36.08 | 2023-2024 | |
| Medtronic, INC. | $16.82 | 2025 | V-Loc 180 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ugonna Ezeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.